A detailed history of Kendall Capital Management transactions in Johnson & Johnson stock. As of the latest transaction made, Kendall Capital Management holds 7,553 shares of JNJ stock, worth $1.17 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
7,553
Previous 7,543 0.13%
Holding current value
$1.17 Million
Previous $1.1 Million 11.07%
% of portfolio
0.39%
Previous 0.38%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$145.48 - $167.38 $1,454 - $1,673
10 Added 0.13%
7,553 $1.22 Million
Q2 2024

Aug 12, 2024

BUY
$144.38 - $157.78 $52,698 - $57,589
365 Added 5.08%
7,543 $1.1 Million
Q4 2023

Jan 26, 2024

BUY
$145.6 - $158.88 $27,227 - $29,710
187 Added 2.67%
7,178 $1.13 Million
Q3 2023

Oct 31, 2023

SELL
$155.75 - $174.48 $17,599 - $19,716
-113 Reduced 1.59%
6,991 $1.09 Million
Q2 2023

Jul 28, 2023

SELL
$154.35 - $166.11 $25,004 - $26,909
-162 Reduced 2.23%
7,104 $1.18 Million
Q1 2023

May 11, 2023

SELL
$151.05 - $180.26 $5,286 - $6,309
-35 Reduced 0.48%
7,266 $1.13 Million
Q4 2022

Jan 30, 2023

SELL
$160.2 - $179.79 $35,083 - $39,374
-219 Reduced 2.91%
7,301 $1.29 Million
Q3 2022

Nov 02, 2022

SELL
$161.33 - $179.52 $6,291 - $7,001
-39 Reduced 0.52%
7,520 $1.23 Million
Q2 2022

Jul 29, 2022

SELL
$168.19 - $186.01 $24,219 - $26,785
-144 Reduced 1.87%
7,559 $1.34 Million
Q1 2022

May 06, 2022

SELL
$158.14 - $179.59 $34,790 - $39,509
-220 Reduced 2.78%
7,703 $1.37 Million
Q4 2021

Jan 28, 2022

BUY
$155.93 - $173.01 $76,093 - $84,428
488 Added 6.56%
7,923 $1.36 Million
Q3 2021

Nov 05, 2021

BUY
$161.5 - $179.47 $110,143 - $122,398
682 Added 10.1%
7,435 $1.2 Million
Q2 2021

Jul 30, 2021

SELL
$159.48 - $171.07 $7,814 - $8,382
-49 Reduced 0.72%
6,753 $1.11 Million
Q1 2021

May 05, 2021

BUY
$153.07 - $170.48 $26,021 - $28,981
170 Added 2.56%
6,802 $1.12 Million
Q4 2020

Feb 08, 2021

BUY
$137.11 - $157.38 $44,972 - $51,620
328 Added 5.2%
6,632 $1.04 Million
Q3 2020

Oct 22, 2020

BUY
$140.38 - $153.83 $100,090 - $109,680
713 Added 12.75%
6,304 $939,000
Q2 2020

Jul 30, 2020

BUY
$128.81 - $155.51 $105,753 - $127,673
821 Added 17.21%
5,591 $786,000
Q1 2020

Apr 27, 2020

BUY
$111.14 - $153.99 $30,674 - $42,501
276 Added 6.14%
4,770 $625,000
Q4 2019

Jan 24, 2020

BUY
$127.5 - $146.44 $34,935 - $40,124
274 Added 6.49%
4,494 $656,000
Q3 2019

Nov 12, 2019

BUY
$126.95 - $142.14 $12,695 - $14,213
100 Added 2.43%
4,220 $546,000
Q2 2019

Aug 09, 2019

BUY
$131.15 - $144.24 $49,181 - $54,090
375 Added 10.01%
4,120 $574,000
Q1 2019

May 08, 2019

BUY
$125.72 - $139.79 $97,433 - $108,337
775 Added 26.09%
3,745 $524,000
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $44,590 - $53,665
-363 Reduced 10.89%
2,970 $383,000
Q3 2018

Oct 29, 2018

BUY
$121.58 - $142.88 $37,568 - $44,149
309 Added 10.22%
3,333 $461,000
Q2 2018

Jul 27, 2018

SELL
$119.4 - $131.76 $2,985 - $3,294
-25 Reduced 0.82%
3,024 $367,000
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $78,187 - $92,587
625 Added 25.78%
3,049 $391,000
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $318,077 - $348,134
2,424
2,424 $339,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Kendall Capital Management Portfolio

Follow Kendall Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kendall Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Kendall Capital Management with notifications on news.